“The role of genomic testing in bladder is expanding almost every year,” says Faltas.
Bishoy M. Faltas, MD, assistant professor of Medicine at Weill Cornell Medicine, explains the growing role of genomic testing in bladder cancer, including the emerging understanding of the role of germline alterations.
